In the largest study of its kind, scientists report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their ...

Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American ...

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

Sequencing CAR T-cell therapy versus bispecific antibodies in myeloma increasingly hinges on MRD depth, transplant candidacy, ...

Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022 The funding sources did not play a role ...

Researchers have introduced a novel diagnostic method that can more sensitively detect gene fusions in B-cell acute ...

Overall, treatment of metastatic triple-positive breast cancer is shifting toward precision-driven regimens that combine HER2 blockade with endocrine and targeted agents tailored to disease burden, ...

Real-world darolutamide safety and effectiveness in nonmetastatic castration-resistant prostate cancer (nmCRPC) by lipid-modifying agent use: Post hoc analyses of DAROL interim analysis 4 (IA4). This ...